SYMLIN® (pramlintide acetate) injection is indicated as an adjunctive treatment in adults with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy.
For US Health Care Professionals|Go to Patient Site Register
US Health Care Professionals